Epidemiological research on safety and efficacy of Yokukansan in the long-term treatment of behavioral and psychological symptoms of dementia.

Epidemiological research on safety and efficacy of Yokukansan in the long-term treatment of behavioral and psychological symptoms of dementia. - Epidemiological research for Yokukansan in the long-term treatment of behavioral and psychological symptoms of dementia.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003593

Enrollment

100

Registered

2010-05-11

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia with behavioral and psychological symptoms

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient who was diagnosed dementia and has BPSD Patient who was prescribed TJ-54 for more than 6 months

Exclusion criteria

Exclusion criteria: When a patient refuses to join the research When a doctor judged a patient not appropriate to join the research based on medical or social reasons

Design outcomes

Primary

Measure	Time frame
Changes in serum potassium level before and after TJ-54 treatment Incidence rate of adverse reaction	—

Secondary

Measure	Time frame
Changes in neuropsychiatric inventory (NPI) score before and after TJ-54 treatment	—

Countries

Japan

Outcome results